FDA NDC Directory · JSON-LD · Markdown

Flucytosine

NDC 50268-331 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAvPAK
Marketing categoryAbbreviated NDA (generic) · App ANDA204652
Dosage form / routeCAPSULE · ORAL
Active ingredientsFLUCYTOSINE (250 mg/1)
Marketing started20210412
Package count1

External sources

Source: openFDA. Public-domain (CC0).